ArticleFrontiers in oncology2026
Gap analysis of breast cancer care at tertiary facilities in Armenia.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is the leading cause of cancer mortality among women globally. Armenia has one of the highest breast cancer mortality rates in the world, with an age standardized mortality-to-incidence ratio of 0.41, indicating that two in five breast cancer patients die from the disease. The factors contributing to this disproportionate mortality burden are poorly understood. The present study utilized a validated survey across four high-capacity cancer facilities to produce a national gap analysis of breast cancer care in Armenia. We find that the tertiary facilities surveyed broadly possess the fundamental technological and personnel resources required for modern breast cancer care; however, it is apparent that challenges exist with early detection, timely diagnosis, and successful treatment. Based on these findings, policy considerations could prioritize breast cancer mortality reduction through early detection, establishment of a cancer registry, streamlining cancer care, and reducing the financial burden of care on patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.